Argentina In-Vitro Diagnostics Market: Growth Dynamics, Opportunities, and Technological Advancements
Fuente:
Zenodo
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Recurso digital |
| Pubblicazione: |
Zenodo
2025
|
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1866901380193583104 |
|---|---|
| author | next move strategy consulting |
| author_facet | next move strategy consulting |
| contents | <p><em>The <a href="https://www.nextmsc.com/report/argentina-in-vitro-diagnostics-market">Argentina In-Vitro Diagnostics (IVD) Market</a> was valued at USD 358 million in 2023 and is projected to reach USD 482 million by 2030, growing at a CAGR of 4% from 2024 to 2030. IVD encompasses laboratory-based testing of biological samples, such as blood, tissues, and bodily fluids, for disease diagnosis, therapy monitoring, and health assessment. Market growth is driven by government investment in public healthcare infrastructure and the rising prevalence of chronic diseases, including diabetes and cardiovascular disorders. The adoption of advanced molecular diagnostics, automated laboratory systems, and point-of-care testing (POCT) devices is creating opportunities for faster, patient-centered care. Challenges include high costs associated with research, development, and regulatory approvals. This manuscript presents a comprehensive overview of the market, including segmentation, key drivers, competitive landscape, and emerging trends in Argentina’s IVD sector.</em></p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_17797785 |
| institution | Zenodo |
| language | |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | Argentina In-Vitro Diagnostics Market: Growth Dynamics, Opportunities, and Technological Advancements next move strategy consulting <p><em>The <a href="https://www.nextmsc.com/report/argentina-in-vitro-diagnostics-market">Argentina In-Vitro Diagnostics (IVD) Market</a> was valued at USD 358 million in 2023 and is projected to reach USD 482 million by 2030, growing at a CAGR of 4% from 2024 to 2030. IVD encompasses laboratory-based testing of biological samples, such as blood, tissues, and bodily fluids, for disease diagnosis, therapy monitoring, and health assessment. Market growth is driven by government investment in public healthcare infrastructure and the rising prevalence of chronic diseases, including diabetes and cardiovascular disorders. The adoption of advanced molecular diagnostics, automated laboratory systems, and point-of-care testing (POCT) devices is creating opportunities for faster, patient-centered care. Challenges include high costs associated with research, development, and regulatory approvals. This manuscript presents a comprehensive overview of the market, including segmentation, key drivers, competitive landscape, and emerging trends in Argentina’s IVD sector.</em></p> |
| title | Argentina In-Vitro Diagnostics Market: Growth Dynamics, Opportunities, and Technological Advancements |
| url | https://doi.org/10.5281/zenodo.17797785 |